Title : Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus.

Pub. Date : 2019 Jun

PMID : 30603867






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The introduction of dipeptidyl peptidase-4 (DPP-4) inhibitors, more than 10 years ago, has provided an alternative to conventional medications for the intensification of glucose-lowering treatment after failure of metformin monotherapy, and therefore, marked an important advance in the management of T2DM. Metformin dipeptidyl peptidase 4 Homo sapiens
2 The introduction of dipeptidyl peptidase-4 (DPP-4) inhibitors, more than 10 years ago, has provided an alternative to conventional medications for the intensification of glucose-lowering treatment after failure of metformin monotherapy, and therefore, marked an important advance in the management of T2DM. Metformin dipeptidyl peptidase 4 Homo sapiens